Literature DB >> 4174433

Studies on a new mechanism of resistance of L5178Y murine leukemia cells to cytosine arabinoside.

R L Momparler, M Y Chu, G A Fischer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4174433     DOI： 10.1016/0005-2787(68)90124-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  13 in total

Review 1.  Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens.

Authors:  W Hiddemann
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

Review 2.  A comparison of the effects of cytosine arabinoside and beta-lactams on DNA synthesis and cellular proliferation.

Authors:  R J Fram
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

3.  Adenosine kinase deficiency in tritiated deoxyadenosine-resistant mouse S49 lymphoma cell lines.

Authors:  K J Sastry; C Huang; T S Chan
Journal:  Biochem Genet       Date:  1987-12       Impact factor: 1.890

Review 4.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

Review 5.  New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase.

Authors:  V W Ruiz van Haperen; G J Peters
Journal:  Pharm World Sci       Date:  1994-04-15

6.  Effect of uracil arabinoside on metabolism and cytotoxicity of cytosine arabinoside in L5178Y murine leukemia.

Authors:  J L Yang; E H Cheng; R L Capizzi; Y C Cheng; T Kute
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

7.  Analysis of the drug synergism between thymidine and arabinosyl cytosine using mouse S49 T lymphoma mutants.

Authors:  A Cohen; B Ullman
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

8.  Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide.

Authors:  M Gore; R Powles; A Lakhani; S Milan; J Maitland; G Goss; A Nandi; T Perren; G Forgeson; J Treleaven
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

9.  Current status of the host-mediated L5178Y system for detecting chemical mutagens.

Authors:  S Y Lee
Journal:  Environ Health Perspect       Date:  1973-12       Impact factor: 9.031

10.  The pharmacologic basis for the efficacy of high-dose Ara-C and sequential asparaginase in adult acute myelogenous leukemia.

Authors:  R L Capizzi; C White
Journal:  Yale J Biol Med       Date:  1988 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.